Companies / BOC Sciences / Bapineuzumab
BOC Sciences

Bapineuzumab | BOC Sciences

Bapineuzumab is a humanized monoclonal antibody that targets the N-terminal region of A_. Bapineuzumab has been investigated in Alzheimer's disease therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.